Can MRI screen for CSF biomarkers in neurodegenerative disease?

Corey T. McMillan, Brian Avants, David J. Irwin, Jon B. Toledo, David A. Wolk, Vivianna M. Van Deerlin, Leslie M. Shaw, John Q. Trojanoswki, Murray Grossman

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Objective: Alzheimer disease (AD) and frontotemporal lobar degeneration (FTLD) may have overlapping clinical presentations despite distinct underlying neuropathologies, thus making in vivo diagnosis challenging. In this study, we evaluate the utility of MRI as a noninvasive screening procedure for the differential diagnosis of AD and FTLD. Methods: We recruited 185 patients with a clinically diagnosed neurodegenerative disease consistent with AD or FTLD who had a lumbar puncture and a volumetricMRI. A subset of 32 patients had genetic or autopsy-confirmed AD or FTLD. We used singular value decomposition to decompose MRI volumes and linear regression and cross-validation to predict CSF total tau (tt) and b-amyloid (Aβ1-42) ratio (tt/Aβ) in patients with AD and patients with FTLD. We then evaluated accuracy of MRI-based predicted tt/Aβ using 4 converging sources including neuroanatomic visualization and categorization of a subset of patients with genetic or autopsy-confirmed AD or FTLD. Results: Regression analyses showed that MRI-predicted tt/Aβ is highly related to actual CSF tt/Aβ. In each group, both predicted and actual CSF tt/Aβ have extensively overlapping neuroanatomic correlates: low tt/Aβ consistent with FTLD is related to ventromedial prefrontal regions while high tt/Aβ consistent with AD is related to posterior cortical regions. MRI-predicted tt/Aβ is 75% accurate at identifying underlying diagnosis in patients with known pathology and in clinically diagnosed patients with known CSF tt/Aβ levels. Conclusion: MRI may serve as a noninvasive procedure that can screen for AD and FTLD pathology as a surrogate for CSF biomarkers.

Original languageEnglish (US)
Pages (from-to)132-138
Number of pages7
JournalNeurology
Volume80
Issue number2
DOIs
StatePublished - Jan 8 2013

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Can MRI screen for CSF biomarkers in neurodegenerative disease?'. Together they form a unique fingerprint.

Cite this